Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Luveris addition to FSH in high-dose ART stimulation (Italy, Phase III)
2004-002218-13Phase 3Completed
- Sponsor
- Industria Farmaceutica Serono
- Start
- Sep 2005
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of lutropin alfa in female infertility (2 arms), sponsored by Industria Farmaceutica Serono. Primary endpoint: FSH dose per oocyte retrieved. Started Sep 2005; status: completed.
02
Drugs
lutropin alfa
03
Conditions
female infertility
Beyond the preview
Go deeper on 2004-002218-13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-002218-13.